Clinical trials
Terminated Phase 1 Osteosarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| AeRang Kim | 1 |
| Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 1 |
| Duke University | 1 |
| GlaxoSmithKline | 1 |
| Innovent Biologics (Suzhou) Co. Ltd. | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
| UNC Lineberger Comprehensive Cancer Center | 1 |
| University of Chicago | 1 |
| Y-mAbs Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteosarcoma | 11 |
| Neuroblastoma | 6 |
| Sarcoma | 5 |
| Neoplasms | 4 |
| Neuroectodermal Tumors, Primitive, Peripheral | 4 |
| Rhabdomyosarcoma | 3 |
| Carcinoma, Hepatocellular | 2 |
| Central Nervous System Neoplasms | 2 |
| Sarcoma, Ewing | 2 |
| Adenocarcinoma of Lung | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.